US Stock MarketDetailed Quotes

EDIT Editas Medicine

Watchlist
  • 1.375
  • -0.035-2.48%
Trading Mar 18 10:44 ET
114.09MMarket Cap-0.48P/E (TTM)

Editas Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Editas Medicine Q4 2024 Earnings Date

Currency：USDMar 5, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
37.17M
30.60M
-6.57M
Miss Est.
-38.10%
-49.03%
-17.67%
EPS
-0.35
-0.55
-0.20
Miss Est.
-52.50%
-139.13%
-56.87%
Analyst Rating
Buy

Mar 18, 2025

Editas Medicine Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 1.286M--
--2025/Q1-- / 786.100K--
Mar 5, 20252024/Q430.604M / 37.171M--
--2024/Q361.000K / 3.894M--
Aug 7, 20242024/Q2513.000K / 4.142M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 1.286M--
--2025/Q1-- / 786.100K--
Mar 5, 20252024/Q430.604M / 37.171M--
--2024/Q361.000K / 3.894M--
Aug 7, 20242024/Q2513.000K / 4.142M--

Unlock Free Earnings Estimates

Editas Medicine Earnings Reports

  • Editas Medicine | 10-K: FY2024 Annual Report

    Mar 5 16:23 ET

  • Editas Medicine | 8-K: Editas Medicine Announces Fourth Quarter and Full Year 2024 Results and Business Updates

    Mar 5 16:12 ET

  • Editas Medicine | 10-Q: Q3 2024 Earnings Report

    Nov 4, 2024 07:39 ET

  • Editas Medicine | 8-K: Editas Medicine Announces Third Quarter 2024 Results and Business Updates

    Nov 4, 2024 07:34 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    YETI Holdings
    YETI
    +1.56%
    Dorian LPG
    LPG
    +0.86%
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    0.00%
    AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
    AIPUY
    0.00%
    Teradata Corp
    TDC
    -0.06%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Mar 18, 2025

    Buy

    • Buy

      37.50%

    • Hold

      50.00%

    • Sell

      12.50%

    Price Target

    No Data

    Investment Theme Gene Editing
    Gene Editing
    Intraday-0.36%